FDA Launches Phase IV Tracking System; Baseline Is 20% Completion Rate
Executive Summary
FDA's Phase IV tracking system shows a 20% completion rate for postmarketing commitments
You may also be interested in...
Phase IV Reporting Improves In Year After FDA Issues Challenge To PhRMA
The pharmaceutical industry appears to be doing a significantly better job in filing Phase IV study updates in a timely fashion, FDA's postmarketing database shows
Phase IV Reporting Improves In Year After FDA Issues Challenge To PhRMA
The pharmaceutical industry appears to be doing a significantly better job in filing Phase IV study updates in a timely fashion, FDA's postmarketing database shows
Phase IV Discussions Should Begin Earlier In Review Process, Wyeth Says
Wyeth wants FDA to direct reviewers to initiate Phase IV discussions with sponsors several weeks before a user fee action date